Pharmaceuticals

Ensuring global access to LP-284

bexib
By bexib 0 Min Read

In this pharmaceutical executive video interview, Lantern Pharma CEO Panna Sharma talks about ensuring global access to LP-284, especially in resource-constrained regions.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article Copywriter moves to X Advertising and grows brand
Next Article First Chinese-made electric car will soon hit the US market
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Processing superalloys while cooling them
Manufacturing
Carlowley Castle announces new venture redefining luxury hospitality, opening doors to Scotland’s luxury estates
Hospitality & Tourism
Fintech funding will “stabilize” in 2025, venture capital prioritizes AI fintech
Banking
6 amazing projects from 2024
Manufacturing